| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Nov 2025 | 17 Oct 2025 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and approve The Board Meeting of the Company will be held on 07/11/2025 to take on record the unaudited financial results for the quarter ended on September 30 2025 and to consider declaration of Interim Dividend for FY 2025-26 and to fix record date for the same. We wish to inform you that Board of Directors in its meeting held today i.e., November 07, 2025 approved the unaudited financial results for the quarter and half year ended September 30, 2025 and declared an interim dividend of Rs. 90/- per equity share of Rs. 10/- each for FY 2025-26 (As Per BSE Announcement Dated on 07.11.2025) | ||
| Board Meeting | 6 Aug 2025 | 21 Jul 2025 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/08/2025 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the quarter ended June 30, 2025 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Outcome of Board Meeting of the Company held on August 06, 2025. (As Per BSE Announcement Dated on :06.08.2025) | ||
| Board Meeting | 11 Jun 2025 | 11 Jun 2025 |
| Pursuant to Regulation 30 of the SEBI LODR Regulations, 2015, we wish to inform you that the Board of Directors at their duly convened meeting held on June 11, 2025, considered, noted, and approved the changes in the directorate of the Company. | ||
| Board Meeting | 26 May 2025 | 5 May 2025 |
| Bayer Cropscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended on March 31 2025 and to consider the recommendation of Final Dividend for the Financial Year 2024-25 if any. We wish to inform you that the Board of Directors at its meeting held on May 26, 2025, recommended a Final Dividend of Rs. 35 per equity share subject to the approval of the shareholders at the forthcoming Annual General Meeting of the Company Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to furnish the Audited Financial Results of the Company along with the Audit Report for the financial year ended on March 31, 2025 from the Statutory Auditors, Deloitte Haskins & Sells LLP (ICAI Firm Registration No. 117366W/W-100018). Also, pursuant to Regulation (33)(3)(d) of the Listing Regulations, we hereby declare that in the respect of Audited Financial Results for the financial year ended March 31, 2025, the statutory auditors have provided an Audit Report with Unmodified opinion. (As per BSE Announcement Dated on 26/05/2025) | ||
| Board Meeting | 11 Feb 2025 | 21 Jan 2025 |
| BAYER CROPSCIENCE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter ended on December 31 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the Outcome of Board Meeting of the Company held on February 11, 2025. Pursuant to Regulation 33 of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors in its meeting held on February 11, 2025 has approved the Unaudited Financial Results for the quarter ended December 31, 2024. We attach a copy of the same along with the Limited Review Report as provided by the Statutory Auditors. (As Per BSE Announcement dated on 11.02.2025) | ||
The business also said that the board of directors recommended a dividend of ₹35 per share. However, details not disclosed yet.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.